Last reviewed · How we verify
MH048
At a glance
| Generic name | MH048 |
|---|---|
| Also known as | MH048 Soft Gel Capsules |
| Sponsor | Minghui Pharmaceutical (Shanghai) LTD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MH048 CI brief — competitive landscape report
- MH048 updates RSS · CI watch RSS
- Minghui Pharmaceutical (Shanghai) LTD portfolio CI